Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities.

Kathleen S Wilson1, Robert W McKenna, Steven H Kroft

  • 1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9073, USA. wilson.kathleen@pathology.swmed.edu

British Journal of Haematology
|February 14, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"A community unlike anything I've ever been a part of": women mountain bikers' experiences of social support.

Frontiers in sports and active living·2026
Same author

Molecular diagnosis of inherited platelet disorder via a targeted whole-exome virtual gene panel: a 5-year institutional experience.

Research and practice in thrombosis and haemostasis·2026
Same author

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

American journal of hematology·2026
Same author

A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Blood advances·2026
Same author

Physical activity as a moderator of the association between central obesity and Type 2 diabetes in Asian American older adults.

Obesity pillars·2025
Same author

The prognostic effect of blast count in <i>TP53</i> mutant myeloid neoplasms -the Minnesota experience.

Leukemia & lymphoma·2024

This study analyzed cytogenetic aberrations in primary effusion lymphoma (PEL). Recurring abnormalities like trisomy 7, 12, and 1q alterations were confirmed, aiding in understanding PEL

Area of Science:

  • Cytogenetics
  • Hematologic Oncology
  • Molecular Biology

Background:

  • Primary effusion lymphoma (PEL) is an aggressive non-Hodgkin lymphoma.
  • Limited cytogenetic data exists for primary PEL specimens.
  • Previous studies focused on PEL cell lines, potentially not reflecting primary disease characteristics.

Purpose of the Study:

  • To characterize the cytogenetic landscape of primary effusion lymphoma.
  • To identify recurring chromosomal abnormalities in PEL.
  • To provide insights into the genetic events driving PEL pathogenesis.

Main Methods:

  • Cytogenetic analysis of 11 effusion specimens from 10 PEL patients.
  • Karyotyping to identify numerical and structural chromosomal aberrations.

Related Experiment Videos

  • Comparison with existing data from PEL cell lines.

    • Main Results:

    • Confirmed trisomy 7, trisomy 12, and aberrations of chromosome 1q as recurring in PEL.
    • Identified specific breakpoints at 3q23, 7p22, 7q22, 10q24, 12q24, 13q22, 14q24, 14q32, 15p11.2, and Xq22.
    • Observed additional recurring abnormalities including +8, +15, +19, +X, and -Y.

    Conclusions:

    • Recurring cytogenetic aberrations in PEL are more complex than previously defined by cell line studies.
    • These findings highlight specific chromosomal regions and breakpoints critical to PEL development.
    • Further investigation into these genetic events can elucidate PEL pathogenesis and inform therapeutic strategies.